eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Novartis Pharmaceuticals UK Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 18/05/2011
PIL Extavia

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 18/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 28/01/2010 and displayed until 18/05/2011
Reasons for adding or updating:
  • Change to date of revision
  • Introduction of new pack/pack size
Updated on 10/07/2009 and displayed until 28/01/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 01/05/2009 and displayed until 10/07/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   interferon beta-1b